Literature DB >> 6893834

Intracellular metabolism of the apoproteins of pulmonary surfactant in rat lung.

R J King, H Martin.   

Abstract

We studied the metabolic turnover of the major apoproteins of pulmonary surfactant from rat lung and compared it with similar studies on the metabolism of dipalmitoyl phosphatidylcholine (DPPC). At varying times after the injection of tritiated leucine or tritiated palmitate we isolated the alveolar cells and alveolar fluid and measured the incorporation of the radioactive leucine into the 35,000-dalton (apoprotein A) and 10,000-dalton (apoprotein B) apoproteins of surfactant and of the radioactive palmitate into DPPC. Maximum labeling of apoprotein A in type II cells occurred within 1 h after injection of the precursor and declined in the next 19 h. The labeling of intracellular DPPC followed the same time course. The labeling of apoprotein B in type II cells was low, and the change of its labeling with time was not consistent with its being secreted by these cells. Both proteins were labeled in alveolar fluid and in alveolar macrophages. The results indicate that apoprotein A is synthesized by type II cells and is probably secreted as part of the surfactant complex. Apoprotein B is not secreted by type II cells with the same time course as apoprotein A or the lipids of surfactant, but our results do not define its origin or physiological purpose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893834     DOI: 10.1152/jappl.1980.48.5.812

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  13 in total

1.  Histochemical characterization of an antigen specific for the great alveolar cell in the mouse lung.

Authors:  F J Van Hemert; A A Ten Have-Opbroek; C J Otto-Verberne
Journal:  Histochemistry       Date:  1986

Review 2.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

3.  Pathway to lamellar bodies for surfactant protein A.

Authors:  Aron B Fisher; Chandra Dodia; Peter Ruckert; Jian-Qin Tao; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

4.  Post-translational modification of the major human surfactant-associated proteins.

Authors:  D S Phelps; J Floros; H W Taeusch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

5.  Degradation of dipalmitoyl phosphatidylcholine by isolated rat granular pneumocytes and reutilization for surfactant synthesis.

Authors:  A Chander; J Reicherter; A B Fisher
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

6.  Immunohistochemical identification of type 2 pneumocytes by an antibody to a lamellar body-enriched fraction of lung homogenate.

Authors:  R K Kumar; A W Lykke; J Y Truscott; S G Watkins; G J Smith
Journal:  Lung       Date:  1985       Impact factor: 2.584

7.  The processing of exogenous cholesterol in the alveolar compartment of the rat lung.

Authors:  P J Hayball; T E Nicholas
Journal:  Lipids       Date:  1989-11       Impact factor: 1.880

8.  An ethanol/ether soluble apoprotein from rat lung surfactant augments liposome uptake by isolated granular pneumocytes.

Authors:  W D Claypool; D L Wang; A Chander; A B Fisher
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Identification of specific proteins synthesized by type II pneumocytes in primary culture.

Authors:  S A Wartell; C K Nafe; C A Watkins; D E Rannels
Journal:  Biochem J       Date:  1983-02-15       Impact factor: 3.857

10.  The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein.

Authors:  A Keller; H R Eistetter; T Voss; K P Schäfer
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.